|
Pronunciation |
|
(klor
fen IR a meen, pye RIL a meen,
& fen il EF rin) |
|
|
U.S. Brand
Names |
|
Rhinatate® Tablet; R-Tannamine®
Tablet; R-Tannate® Tablet; Rynatan® Pediatric Suspension;
Rynatan® Tablet; Tanoral® Tablet; Triotann® Tablet;
Tri-Tannate®
Tablet |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Antihistamine/Decongestant Combination |
|
|
Use |
|
Symptomatic relief of nasal congestion associated with upper respiratory
tract condition |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Usual Dosage |
|
Children:
2-6 years: 2.5-5 mL every 12 hours
>6 years: 5-10 mL every 12 hours |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
Use with caution since phenylephrine is a sympathomimetic amine which could
interact with epinephrine to cause a pressor response |
|
|
Dental Health:
Effects on Dental Treatment |
|
Chlorpheniramine: Prolonged use will cause significant xerostomia
Phenylephrine: Up to 10% of patients could experience tachycardia,
palpitations, and dry mouth; use vasoconstrictor with caution
|
|
|
Patient
Information |
|
May cause drowsiness. Alcohol, sedatives, and tranquilizers may worsen this
effect. Use caution while driving or operating machinery. |
|
|
Dosage Forms |
|
Liquid: Chlorpheniramine tannate 2 mg, pyrilamine tannate 12.5 mg, and
phenylephrine tannate 5 mg per 5 mL
Tablet: Chlorpheniramine tannate 8 mg, pyrilamine maleate 12.5 mg, and
phenylephrine tannate 25 mg |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|